Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,264 | 5,365 | 1,925 | 2,449 | 1,753 |
| Receivables | 21 | 53 | 50 | 16 | 47 |
| Other current assets | 15 | 15 | 15 | 15 | 31 |
| TOTAL | $4,808 | $5,919 | $2,408 | $2,832 | $2,189 |
| Non-Current Assets | |||||
| PPE Net | 234 | 212 | 220 | 247 | 279 |
| Intangibles | 472 | 438 | 425 | 435 | 448 |
| TOTAL | $706 | $650 | $646 | $683 | $726 |
| Total Assets | $5,514 | $6,568 | $3,054 | $3,515 | $2,915 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 149 | 227 | 439 | 308 | 709 |
| Accrued Expenses | 64 | 75 | 41 | 45 | 99 |
| Other current liabilities | 3 | 3 | 3 | 3 | 3 |
| TOTAL | $216 | $305 | $484 | $359 | $1,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 2 | 6 |
| Other Non-Current Liabilities | 1,176 | 0 | 0 | 0 | 33 |
| TOTAL | $1,176 | $N/A | $N/A | $N/A | $33 |
| Total Liabilities | $1,392 | $305 | $484 | $359 | $1,690 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10 | 10 | 10 | 9 | 9 |
| Common Shares | 722 | 721 | 655 | 651 | 612 |
| Retained earnings | -95,960 | -89,759 | -88,865 | -87,660 | -86,554 |
| Other shareholders' equity | -14 | 0 | 0 | 0 | 0 |
| TOTAL | $4,122 | $6,263 | $2,570 | $3,156 | $1,225 |
| Total Liabilities And Equity | $5,514 | $6,569 | $3,054 | $3,515 | $2,915 |